Laura Horowitz

ORCID: 0009-0002-3376-9636
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dialysis and Renal Disease Management
  • Hemodynamic Monitoring and Therapy
  • Central Venous Catheters and Hemodialysis
  • Renal Transplantation Outcomes and Treatments
  • Gastroesophageal reflux and treatments
  • Health and Conflict Studies
  • Potassium and Related Disorders
  • Chronic Kidney Disease and Diabetes
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Neurological Complications and Syndromes
  • Body Composition Measurement Techniques
  • Vascular Procedures and Complications
  • Nosocomial Infections in ICU
  • Disaster Response and Management

McGill University Health Centre
2022-2024

St. Michael's Hospital
2023

University of Toronto
2023

McGill University
2022

Key Points In a large multinational cohort of PD patients, any GAS use was not associated with an increased risk all-organism peritonitis. For peritonitis, risks were particularly high among certain classes organisms for Gram-negative, enteric, and streptococcal peritonitis episodes. The association enteric appeared to be stronger H2RA users. Background Peritonitis is major peritoneal dialysis–related complication. We determined whether gastric acid suppression (GAS) (proton pump inhibitor...

10.34067/kid.0000000000000325 article EN cc-by-nc-nd Kidney360 2023-11-28

Peritoneal dialysis (PD) pericatheter exit-site leaks most commonly occur early, within 30 days of catheter insertion. Late are rare. The distinction between early and late is important because the causes subsequent management strategies may be different. Early can often first treated by delaying or holding PD therapy, allowing prolongation healing time fibrous tissue continues to form around deep cuff. less likely heal with cessation alone require replacement. In this case report, we...

10.1016/j.xkme.2023.100647 article EN cc-by-nc-nd Kidney Medicine 2023-05-04

Background: Kidney transplant recipients (KTR) who return to dialysis (RTD) have high morbidity. Whether continue immunosuppression (IS) after RTD remains uncertain and involves balancing IS-related risks with preventing terminal rejection allo-sensitization that may preclude re-transplantation. Objectives: We conducted a quality improvement study characterize IS practices following RTD, determine incidence of potential complications, catastrophic events, re-transplantation for patients in...

10.1097/01.tp.0000888684.41744.76 article EN Transplantation 2022-09-01

Horowitz, Laura; Karadjian, Oliver A.; Mavrakanas, Thomas; Weber, Catherine L. Author Information

10.1681/asn.20223311s1700b article EN Journal of the American Society of Nephrology 2022-11-01
Coming Soon ...